Nico Stam

Nico Stam

Chief Business Officer at Maastricht Health Campus

Startupbootcamp Smart Materials Sittard Mentor

Nico Stam joined Brightlands Maastricht Health Campus on March 1st, 2015 as Chief Business Officer, to put his 25 years of expertise in M&A, Business Development, and research management at pharmaceutical industry into practice, to assist start-up companies setting up their business towards the next round of funding.

Nico joined Organon Pharmaceuticals in 1990 where he held several positions in R&D related to the discovery and development of novel drugs. From 1998 to 2001 he headed the Department of Target Discovery of Organon in the UK. From 2002 to 2004 he was Alliance manager of a large R&D & commercialization alliance between Organon and Sanofi in the area of antithrombotics and where he was involved in the worldwide launch of a new antithrombotic drug. In 2004, he joint the Strategy & Licensing department at headquarters where he was responsible for the strategic assessment and financial valuation of Organon’s R&D portfolio for the cardiovascular and neuroscience program. During this period, he coordinated several significant licensing deals and divestment projects to strengthen the company’s portfolio. In 2007 he joined Organon Biosciences in the position of Executive Director Global Strategy & Mergers and Acquisitions. From 2007 to end 2009 he worked at Schering-Plough as European Head of BD and Business Partnerships. In 2010 he joined Merck & Co. with responsibility for the worldwide licensing strategy of Merck’s Women’s Health & Endocrine franchise. As Executive Director at Merck he managed in the period 2012 to 2015, a significant number of outlicensing deals of discontinued Merck R&D projects to external parties, including venture capitalists, start-up companies, as well as to other pharmaceutical and biotech companies. Nico studied biochemistry at the Free University Amsterdam and received his PhD in cell biology at the Netherlands Cancer Institute, Amsterdam where he studied gene regulation and expression of transplantation antigens in malignant cells.